On 14 de out. de 2025, JNJ reported earnings of 2.80 USD per share (EPS) for Q3 25, beating the estimate of 2.78 USD, resulting in a 0.55% surprise. Revenue reached 23.99 bilhão, compared to an expected 23.99 bilhão, with a 0.03% difference. The market reacted with a -0.03% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 analistas forecast an EPS of 2.55 USD, with revenue projected to reach 24.37 bilhão USD, implying an diminuir of -8.93% EPS, and aumentar of 1.57% in Revenue from the last quarter.
FAQ
What were Johnson & Johnson's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Johnson & Johnson reported EPS of $2.80, beating estimates by 0.55%, and revenue of $23.99B, 0.03% above expectations.
How did the market react to Johnson & Johnson's Q3 2025 earnings?
The stock price moved down -0.03%, changed from $190.90 before the earnings release to $190.85 the day after.
When is Johnson & Johnson expected to report next?
The next earning report is scheduled for 21 de jan. de 2026.
What are the forecasts for Johnson & Johnson's next earnings report?
Based on 18
analistas, Johnson & Johnson is expected to report EPS of $2.55 and revenue of $24.37B for Q4 2025.